Adagene (ADAG) Partners With Incyte (INCY) to Evaluate Combination Therapy for Colorectal Cancer

Adagene Inc. (NASDAQ:ADAG) is 1 of the unstoppable stocks that could treble your money. On April 2, Adagene announced a objective collaboration with Incyte Corp. (NASDAQ:INCY) to measure a caller operation therapy for microsatellite unchangeable colorectal cancer/MSS CRC. The survey volition harvester Adagene’s muzastotug/ADG126, which is simply a masked anti-CTLA-4 SAFEbody, with Incyte’s INCA33890, a bispecific antibody targeting TGFβR2 and PD-1.

This Phase 1 trial, expected to statesman successful 2026, volition absorption connected third-line patients some with and without liver metastases, a radical that typically faces a mediocre prognosis and constricted effect to modular immunotherapies. The collaboration uses muzastotug’s imaginable arsenic a backbone therapy, designed to summation the therapeutic scale by selectively activating successful the tumor microenvironment. While Incyte volition sponsor and behaviour the trial, Adagene volition supply the objective proviso of muzastotug.

Photo by National Cancer Institute connected Unsplash

This marks a important enlargement of muzastotug’s objective portfolio, which already includes promising information successful operation with pembrolizumab, wherever it achieved a 31% wide effect complaint successful circumstantial high-dose cohorts for late-line MSS CRC patients. Additionally, Adagene Inc. (NASDAQ:ADAG) precocious released updated information from its ongoing Phase 1b/2 study, showing that muzastotug successful operation with pembrolizumab achieved a median wide endurance of 19.8 months successful the 10 mg/kg cohorts.

Adagene Inc. (NASDAQ:ADAG) is simply a biotechnology institution that specializes successful monoclonal antibody drugs for cancers. The company’s divers pipeline of objective & preclinical oncology candidates includes its pb anti-CTLA-4 antibody ADG126 and assorted mAb & bispecific programs.

While we admit the imaginable of ADAG arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.